A Survey of Attitudes of Experienced Blood Donors

February 21, 2019 updated by: Christopher R. France, Ph.D., Ohio University
This study examines the effects of a web-based motivational interview on 1) internal motivation to donate blood; 2) donor autonomy, competence and relatedness; and 3) donation intention and behavior. The study also evaluates whether group differences in donation intention and behavior are mediated by autonomy, competence, and relatedness, and in turn, internal motivation.

Study Overview

Detailed Description

Voluntary blood donation is both important and necessary for the provision of a steady and safe blood supply. With an aging population and increased restrictions on who can donate blood, maintenance of a stable blood supply is essential. Although 38% of the United States population is eligible to donate, only 5% actually does so. Retention of donors is essential to assuring the continuity of a safe blood supply; repeat donors are safer, more cost effective, and less likely to experience adverse reactions. Current recruitment and retention methods may not be sufficient to encourage repeat donations. According to Self-Determination Theory, people are more likely to persist with behaviors that are internally versus externally motivated. Internal motivation is enhanced by supporting an individual's needs for autonomy, competence, and relatedness. One intervention that has shown early promise as a novel method to enhance internal motivation to donate blood is motivational interviewing. However, implementation of a motivational interviewing intervention is costly and time consuming. Given the time and money required for training and delivery of a motivational interviewing intervention, the current study is designed to test the efficacy of a newly-developed web-based version of a motivational interview. Participants will be randomly assigned to complete either an on-line motivational interview about their blood donation experience or an on-line knowledge interview about blood donation.

Study Type

Interventional

Enrollment (Actual)

1177

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Athens, Ohio, United States, 45701
        • Ohio University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject donated blood within the last week with New York Blood Center.
  • Subject has made 2 or more blood donations.
  • Subject is eligible to donate blood again.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Motivational Interview
Complete an on-line motivational interview regarding participants' blood donation experience.
A web-based computer-tailored intervention that includes open-ended questions, reflective responses, affirmations, and summarizing, as well as informing and advising. Specific topics include 1) individual motivations for giving, 2) the relationship between past donation behavior and the individual's personal goals/values, 3) donation importance and confidence rulers, 4) addressing donor concerns, and 5) summarizing.
Placebo Comparator: Knowledge Interview
Complete an on-line interview regarding participants' general knowledge about blood donation.
A web-based interview that includes open-ended questions regarding blood donation knowledge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood donation attempts
Time Frame: 60 weeks after index donation
The number of blood donation attempts since their study participation will be obtained from the participants' donor records.
60 weeks after index donation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Donation Intention
Time Frame: on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Intent to donate blood within the next 8 weeks will be assessed using three questions on a 7-point Likert-type scale, from 1 (disagree) to 7 (agree): I plan to donate blood in the next 8 weeks., How likely is it that you will donate blood in the next 8 weeks? and I will donate blood in the next 8 weeks. Total scores on the scale range from 3 to 21, with higher scores indicating greater intention to donate.
on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Donation Attitude
Time Frame: on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Attitudes toward blood donation will be assessed using a 6-item measure where individuals are asked to rate how donating blood in the next 8 weeks would seem using a 7-item Likert-type scale. The scale distinguishes between cognitive attitudes (evaluative judgments: useful versus useless, pointless versus worthwhile, the wrong thing to do versus the right thing to do) and affective attitudes (emotional reactions: unpleasant versus pleasant, unenjoyable versus enjoyable, frightening versus not frightening). Total scores on the scale range from 6 to 42, with higher scores reflecting more positive attitudes toward blood donation.
on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Donation Perceived Behavioral Control
Time Frame: on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Individuals' perception of control over their ability to donate blood will be assessed using a 6-item measure that assesses two components of perceived behavioral control: self-efficacy (three items) and controllability (three items). Items on the self-efficacy sub-scale ask about how confident the participant is in their ability to donate blood in the next 8 weeks, while the controllability sub-scale assesses how much control participants feel they have over whether or not they donate blood. Participants are asked to rate each item on a 7-point Likert-type scale. Total scores on the scale range from 6 to 42, with higher scores reflecting greater perception of control over ones ability to donate blood.
on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Donation Subjective Norms
Time Frame: on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Individuals' perception about subjective norms will be assessed using a six item, 7-point Likert-type scale, with anchors at 1 (disagree/unlikely) and 7 (agree/likely). Total scores on the scale range from 6 to 42. The measure assesses both descriptive norms (perceived behavior of others) and injunctive norms (what an individual believes others want from him/her).
on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Blood Donor Identity
Time Frame: on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Blood Donor Identity will be measured using an 18-item scale that examines an individual's motivation to donate on the six motivational factors proposed by Self Determination Theory: amotivation, external regulation, introjected regulation, identified regulation, integrated regulation, and intrinsic regulation. Participants are asked to rate their agreement with each item on a 7-point Likert-type scale, with individual item scores ranging from 1 (not at all true) to 7 (very true). A composite score for the total scale is calculated by combining the six subscale scores using the weighting of -3, -2, -1, +1, +2, +3 for the amotivation, external regulation, introjected regulation, identified regulation, integrated regulation, and intrinsic regulation subscales, respectively, in order to produce a single Relative Autonomy Index score.
on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Blood Donation Anxiety
Time Frame: on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Anxiety will be assessed using the Blood Donor Anxiety Scale, a six-item scale that assesses for both the presence (3 items) and absence (3 items) of anxiety. Participants rate their agreement on how relaxed, content, pleasant, tense, nervous and jittery they would feel if they donated blood on a 4-point scale, with anchors at 1 (not at all) and 4 (very much). Composite scores on the scale range from 3 to 12, with higher scores on the presence subscale reflecting more anxiety, and higher scores on the absence subscale reflecting less anxiety about a future donation.
on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Blood Donor Ambivalence
Time Frame: on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
The 6-item ambivalence scale asks participants to rate how true a statement is for them on a 7-point scale (1=Not at all true to 7=Very true). Separate subscale scores are calculated for commitment and indecision (scores ranging from 3 to 21 for each subscale).
on average 1 week after index donation; on average 2 days after interview; on average 7 weeks after interview
Psychological Need Support
Time Frame: on average 2 days after interview
To assess whether the Motivational Interview intervention supported the basic psychological needs of autonomy, competence, and relatedness, a 9-item Likert-type scale will be utilized (3 items per psychological need, anchors at 1 = Not at All and 7 = Extremely).
on average 2 days after interview
Treatment Evaluation
Time Frame: on average 2 days after interview
Participants will be asked a series of questions regarding their experience during the interview.
on average 2 days after interview

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 3, 2017

Primary Completion (Actual)

November 1, 2018

Study Completion (Actual)

November 1, 2018

Study Registration Dates

First Submitted

March 22, 2017

First Submitted That Met QC Criteria

April 4, 2017

First Posted (Actual)

April 5, 2017

Study Record Updates

Last Update Posted (Actual)

February 25, 2019

Last Update Submitted That Met QC Criteria

February 21, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 16-X-331

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

De-identified participant data may be obtained after data collection is completed. Individual participant data requests should be directed to the Principal Investigator.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Blood Donors

Clinical Trials on Motivational Interview

3
Subscribe